Supplement to Association of cutaneous immune-related adverse events with improved overall survival among patients with cutaneous squamous cell carcinoma treated with palliative PD-1 inhibition

Name: Supplement to Association of cutaneous immune-related adverse events with improved overall survival among patients with cutaneous squamous cell carcinoma treated with palliative PD-1 inhibition
Creator: Frederick Gibson
Published: 2025-01-31T10:00:32.534Z
Keywords: Immunotherapy, Squamous Cell Carcinoma

Gibson, Frederick

doi:10.17632/2fz478mzyn.1

Supplement to Association of cutaneous immune-related adverse events with improved overall survival among patients with cutaneous squamous cell carcinoma treated with palliative PD-1 inhibition

Published: 31 January 2025| Version 1 | DOI: 10.17632/2fz478mzyn.1

Contributor:

Frederick Gibson

Description

Supplement to Association of cutaneous immune-related adverse events with improved overall survival among patients with cutaneous squamous cell carcinoma treated with palliative PD-1 inhibition

Supplement to Association of cutaneous immune-related adverse events with improved overall survival among patients with cutaneous squamous cell carcinoma treated with palliative PD-1 inhibition

Description

Files

Categories

Licence